Search

Author/Creator Janku, F

1. Ultra-deep next-generation sequencing of plasma cell-free DNA in patients with advanced lung cancers: results from the Actionable Genome Consortium. (20th March 2019)

Authors:
Li, B T; Janku, F; Jung, B; Hou, C; Madwani, K; Alden, R; Razavi, P; Reis-Filho, J S; Shen, R; Isbell, J M; Blocker, A W; Eattock, N; Gnerre, S; Satya, R V; Xu, H; Zhao, C; Hall, M P; Hu, Y; Sehnert, A J; Brown, D
Journal:
Annals of oncology
Issue:
Volume 30:Number 4(2019)
Page Start:
597
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 418PDNCI-MATCH Arms N & P: Phase II study of PI3K beta inhibitor GSK2636771 in patients (pts) with cancers (ca) with PTEN mutation/deletion (mut/del) or PTEN protein loss. (23rd October 2018)

Authors:
Janku, F; Jegede, O; Puhalla, S L; Konstantinopoulos, P; Meric-Bernstam, F; Mitchell, E P; Zwiebel, J A; McShane, L M; Li, S; Rubinstein, L V; Doyle, L A; Patton, D; Conley, B A; O'Dwyer, P J; Harris, L N; Arteaga, C; Williams, P M; Hamilton, S R; Chen, A P; Flaherty, K T
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. 1603OInitial results of phase I study of DCC-2618, a broad-spectrum KIT and PDGFRa inhibitor, in patients (pts) with gastrointestinal stromal tumor (GIST) by number of prior regimens. (23rd October 2018)

Authors:
George, S; Heinrich, M; Chi, P; Razak, A; von Mehren, M; Gordon, M; Ganjoo, K N; Somaiah, N; Trent, J C; Rodon Ahnert, J; Wolf, J; Ruiz-Soto, R; Rosen, O; Janku, F
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗